US6025346AExpiredUtility

1α-hydroxy vitamin D4 and novel intermediates and analogues

55
Assignee: BONE CARE INT INCPriority: Sep 21, 1990Filed: Jun 24, 1994Granted: Feb 15, 2000
Est. expirySep 21, 2010(expired)· nominal 20-yr term from priority
A61K 8/606C07C 35/21A61Q 19/00A61K 8/67A61K 31/592A61K 31/59C07C 401/00
55
PatentIndex Score
16
Cited by
66
References
4
Claims

Abstract

Disclosed is 1 alpha ,24-dihydroxy vitamin D4 having the following structure: and pharmaceutical compositions containing said compound. The compound and composition are useful in the treatment of abnormal calcium metabolism. Also Disclosed is a method for the preparation of 1 alpha ,24-dihydroxy vitamin D4.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. 1α,24 dihydroxy vitamin D 4 . 
     
     
       2. A pharmaceutical composition, comprising an amount effective to increase serum calcium in a patient suffering Vitamin D deficiency of 1α,24 dihydroxy vitamin D 4  in combination with a pharmaceutically acceptable vehicle. 
     
     
       3. The pharamaceutical composition of claim 2, wherein said amount is administered orally. 
     
     
       4. 1α,24-dihydroxyvitamin D 4  produced in accordance with the method comprising incubating 1α-hydroxyvitamin D 4  with cultured human liver cells to form 1α,24-dihydroxyvitamin D 4 , and isolating and purifying the 1α,24-dihydroxyvitamin D 4  via high pressure liquid chromatography.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.